Along with our advocacy, legislative, and public education work, litigation is one of the fundamental ways the ACLU of Hawai‘i fights for equality and civil liberties. See below for more information on the cases we've brought to the courts.

UPDATE: Due to the large volume of legal intake requests we receive and the limited resource we have, as of July 1st, 2021, the ACLU of Hawai‘i will no longer be sending responses to every legal intake request that we receive. In short, if you submitted an intake request after this date, please do not expect a response from us.

While we may not respond to your specific intake request, we are still reviewing and tracking all intake requests. We may follow up with you regarding your request if we need or would like more information.

You should not treat a lack of response as a sign that you do or do not have a viable legal claim. A lack of response also should not discourage you from pursuing a resolution through other avenues. 

There may be legal time limits or other deadlines that affect your claims. To protect your rights in time-sensitive matters, you may wish to contact a private attorney. The Hawai‘i Legal Aid Society provides information on common legal problems and the Hawai‘i State Bar Attorney Referral Service can help you find a lawyer.

NOTE: The completion of this intake form does not mean that the ACLU of Hawai‘i is providing, or will provide, you legal representation.

If you wish to request legal assistance, please click here.

Filter Cases

A.B. et al. v. Hawai‘i DOE and OIA

In December 2018, the ACLU of Hawaiʻi, together with Legal Aid at Work and Simpson Thacher & Barlett, filed a Title IX class action lawsuit on behalf of brave Campbell High School female student-athletes against the Hawaiʻi DOE and the OIA seeking gender equity in school athletics.

December 6, 2018 Gender Equity

Chelius v. Azar

In October 2017, the American Civil Liberties Union and the ACLU of Hawaiʻi filed suit on behalf of a Kauai doctor and several professional health care associations to challenge Food and Drug Administration restrictions that significantly limit access to medication abortion.

October 3, 2017